' Major Advancement ' in Preventing Neutropenia, Says Trialist ' Major Advancement ' in Preventing Neutropenia, Says Trialist

Growth factors have been the standard of care for preventing chemotherapy-induced neutropenia for decades. Could adding a new agent improve efficacy, and what should be the measure of that efficacy?Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news